News Archive

March 25, 2026

Process-Driven Cadence: Biotech IPOs Demystified

  • LifeSciVC
Read more
March 18, 2026

Balancing the Risks and Rewards of Drug Development in China: A Small Biotech CEO Perspective

  • From the Trenches
Read more
March 13, 2026

Ex-US Clinical Trials: Tribulations, Preparations, and Expectations

  • From the Trenches
Read more
March 11, 2026

With $100M, Vima pursues an oral drug for movement disorders

  • Portfolio Company News
Read more
March 6, 2026

Servier to buy Day One Biopharma for $2.5 billion in tumor treatment push

  • Portfolio Company News
Read more